Ionis Pharmaceuticals | IONS - Gross Profit On Sales


Ionis Pharmaceuticals reported $243M in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
Agios Pharmaceuticals USD 19.43M 1.34M Mar/2026
Alnylam Pharmaceuticals USD 825M 4.3M Mar/2026
Arrowhead Research USD 264.03M 7.56M Dec/2025
Astellas Pharma JPY 444.26B 12.55B Mar/2026
BioCryst Pharmaceuticals USD 153.05M 4.16M Dec/2025
BioMarin Pharmaceutical USD 571.21M 141.8M Mar/2026
Celltrion KRW 46.98B 579.12B Dec/2025
Cspc Pharmaceutical CNY 4.01B 329.18M Dec/2025
Deva Holding AS TRY 1.32B 235.77M Sep/2023
Divis Laboratories Ltd INR 16.59B 2.05B Dec/2025
Esperion Therapeutics USD 140.59M 94.57M Dec/2025
Exelixis USD 590.86M 18.68M Mar/2026
Halozyme Therapeutics USD 297.47M 75.53M Mar/2026
Ionis Pharmaceuticals USD 243M 48M Mar/2026
Kangmei Pharma CNY 270.29M 20.26M Sep/2025
Knight Therapeutics CAD 64.72M 8.91M Dec/2025
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Medical Developments International AUD 7.35M 7.37M Jun/2025
Moderna USD -566M 792M Mar/2026
Nektar Therapeutics USD 21.81M 8.06M Dec/2025
Neuren Pharmaceuticals AUD 6.69M 6.37M Jun/2025
Neurocrine Biosciences USD 800.7M 12.8M Mar/2026
Novartis USD 10.07B 184M Mar/2026
Omeros USD -33.16M 18.52M Jun/2024
OPKO Health USD 45M 1.89M Dec/2025
Organigram Holdings CAD 23.32M 8.52M Dec/2025
Pfizer USD 11.04B 1.24B Mar/2026
Pharma Mar EUR 39.24M 47.46M Mar/2026
PTC Therapeutics USD 232.94M 84.56M Mar/2026
Qiagen NV USD 325.27M 19.53M Dec/2025
Regeneron Pharmaceuticals USD 2.94B 363.7M Mar/2026
Roche Holding CHF 22.09B 10.04B Dec/2025
Sarepta Therapeutics USD 621.34M 577.79M Mar/2026
Sartorius EUR 414.5M 18.3M Mar/2026
Sino Biopharmaceutical CNY 10.5B 2.53B Dec/2024
Tilray USD 57.47M 10.16M Jun/2025
Ultragenyx Pharmaceutical USD 106M 72M Mar/2026
Vertex Pharmaceuticals USD 2.6B 121.7M Mar/2026
Zealand Pharma A/S 68.91M 19.35M Dec/2025
Zz Pientze Pharmaceu CNY 1.16B 860.2M Mar/2026